Calithera Biosciences (CALA) Competitors

Athersys (NASDAQ:ATHX) and Calithera Biosciences (NASDAQ:CALA) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, profitability, valuation, community ranking, analyst recommendations, dividends, earnings, media sentiment and risk.

Which has higher valuation and earnings, ATHX or CALA?

Calithera Biosciences has higher revenue and earnings than Athersys.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Athersys	$146K	0.00	-$72.53M	-$2.03	N/A
Calithera Biosciences	$9.75M	0.01	-$39.65M	N/A	N/A

Is ATHX or CALA more profitable?

Company	Net Margins	Return on Equity	Return on Assets
Athersys	N/A	N/A	-223.03%
Calithera Biosciences	N/A	N/A	N/A

Do analysts rate ATHX or CALA?

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Athersys	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A
Calithera Biosciences	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Do insiders and institutionals have more ownership in ATHX or CALA?

19.4% of Athersys shares are owned by institutional investors. 0.0% of Athersys shares are owned by insiders. Comparatively, 6.6% of Calithera Biosciences shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Which has more volatility & risk, ATHX or CALA?

Athersys has a beta of -0.9, indicating that its share price is 190% less volatile than the S&P 500. Comparatively, Calithera Biosciences has a beta of -0.18, indicating that its share price is 118% less volatile than the S&P 500.

Does the MarketBeat Community believe in ATHX or CALA?

Athersys received 24 more outperform votes than Calithera Biosciences when rated by MarketBeat users. Likewise, 59.54% of users gave Athersys an outperform vote while only 58.69% of users gave Calithera Biosciences an outperform vote.

Company	Underperform	Outperform
Athersys	Outperform Votes 365 59.54%	Underperform Votes 248 40.46%
Calithera Biosciences	Outperform Votes 341 58.69%	Underperform Votes 240 41.31%

Does the media refer more to ATHX or CALA?

In the previous week, Athersys had 1 more articles in the media than Calithera Biosciences. MarketBeat recorded 1 mentions for Athersys and 0 mentions for Calithera Biosciences. Calithera Biosciences' average media sentiment score of 0.23 beat Athersys' score of 0.00 indicating that Athersys is being referred to more favorably in the media.

Company	Overall Sentiment
Athersys	Neutral
Calithera Biosciences	Neutral

Summary

Athersys and Calithera Biosciences tied by winning 5 of the 10 factors compared between the two stocks.